California Public Employees Retirement System’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,660
Closed -$430K 3186
2021
Q1
$430K Hold
27,660
﹤0.01% 3042
2020
Q4
$439K Sell
27,660
-3,098
-10% -$46.7K ﹤0.01% 2988
2020
Q3
$374K Buy
30,758
+1,360
+5% +$18.2K ﹤0.01% 2954
2020
Q2
$340K Buy
+29,398
New +$405K ﹤0.01% 2947
2019
Q4
Sell
-2,400
Closed -$13K 3443
2019
Q3
$13K Buy
+2,400
New +$15.9K ﹤0.01% 3241

Other funds holding KDNY

California Public Employees Retirement System's KDNY Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q2 2021, closing a stake of 27,660 shares — an estimated $430K sold.

California Public Employees Retirement System first reported a position in KDNY in Q3 2019 and held it in 5 quarters. The position peaked at $439K in Q4 2020. 89 funds tracked by Wall St. Rank hold KDNY as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 27,660 Chinook Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $430K.
  • California Public Employees Retirement System first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
  • California Public Employees Retirement System's Chinook Therapeutics, Inc. Common Stock position peaked at $439K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.